J. C. Madelmont

944 citations

53 papers · 800 indexed · h-index 15

Biochemistry top 5%
- Amino Acid Enzymes and Metabolism 8
Biotechnology top 10%
- Cancer Research and Treatments 4
Pharmaceutical Science top 10%
Cancer Research
- Cancer, Hypoxia, and Metabolism 6
Molecular Biology
- Cancer therapeutics and mechanisms 8
- DNA Repair Mechanisms 4
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 5
Oncology
- Drug Transport and Resistance Mechanisms 4
- Metal complexes synthesis and properties 4

Co-authors: Janine Papon Daniel Morvan Aïcha Demidem J. C. Maurizis P. Chollet Eric Cellarier Nicole Moins Marie‐Paule Vasson
Cited by: Biochemistry Biotechnology Pharmaceutical Science
Partner nations: France Canada Mali

In The Last Decade

J. C. Madelmont

52 papers receiving 783 citations

Peers

Countries citing papers authored by J. C. Madelmont

Since Specialization

Citations

This map shows the geographic impact of J. C. Madelmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. Madelmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. Madelmont more than expected).

Fields of papers citing papers by J. C. Madelmont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. Madelmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. Madelmont. The network helps show where J. C. Madelmont may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. C. Madelmont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. C. Madelmont Line = papers co-authored together J. C. Madelmont links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Melanoma vectorized radiotherapy: preclinical evaluation of a new marker labelled by iodine 131 Mathilde Bonnet,Janine Papon,Elisabeth Miot‐Noirault,J. C. Madelmont,Jean‐Michel Chezal,Nicole Moins,Florence Mishellany,F. Penault-Llorca,Anne Cayre	2010	1
2	N-4-iodophenyl-N′-2-chloroethylurea, a novel potential anticancer agent with colon-specific accumulation: radioiodination and comparative in vivo biodistribution profiles Emmanuelle Mounetou,Elisabeth Miot-Noirault,René C.‐Gaudreault,J. C. Madelmont	2009	8
3	Proteomic studies of B16 lines: Involvement of Annexin A1 in melanoma dissemination Fabien Rondepierre,Bernadette Bouchon,Janine Papon,Mathilde Bonnet,Roselyne Kintossou,Nicole Moins,J. Maublant,J. C. Madelmont,M. D’Incan,Françoise Degoul	2008	40
4	Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent Delphine Denoyer,P. Labarre,Janine Papon,Elisabeth Miot‐Noirault,Marie‐Josèphe Galmier,J. C. Madelmont,Jean‐Michel Chezal,Nicole Moins	2008	13
5	A New O6-Alkylguanine-DNA Alkyltransferase Inhibitor Associated with a Nitrosourea (Cystemustine) Validates a Strategy of Melanoma-Targeted Therapy in Murine B16 and Human-Resistant M4Beu Melanoma Xenograft Models Maryse Rapp,J. C. Maurizis,Janine Papon,P. Labarre,Ting‐Di Wu,Alain Croisy,Jean‐Luc Guerquin‐Kern,J. C. Madelmont,Emmanuelle Mounetou	2008	7
6	N-(4-iodophenyl)-N′-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice Michèle Borel,Françoise Degoul,Yves Communal,Emmanuelle Mounetou,Bernadette Bouchon,René C-Gaudreault,J. C. Madelmont,Elisabeth Miot-Noirault	2007	13
7	Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells A relay for chemotherapy? Aïcha Demidem,Daniel Morvan,J. C. Madelmont	2006	35
8	Liver protein synthesis stays elevated after chemotherapy in tumour-bearing mice S. E. Samuels,T. T. McLaren,Alessandra Knowles,S. Evelyn Stewart,J. C. Madelmont,Didier Attaix	2005	5
9	Methionine dependency and cancer treatment Eric Cellarier,Xavier Durando,Marie‐Paule Vasson,M.‐C. Farges,A Demiden,J. C. Maurizis,J. C. Madelmont,P. Chollet	2003	167
10	Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: Demonstration of phospholipid metabolism alterations Daniel Morvan,Aïcha Demidem,Janine Papon,J. C. Madelmont	2003	44
11	Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent P. Labarre,Janine Papon,Marie‐France Moreau,Nicole Moins,Martine Bayle,A. Veyre,J. C. Madelmont	2002	33
12	Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients Eric Cellarier,C. Terret,P. Labarre,R. Ouabdesselam,H. Curé,C�cile Marchenay,J. C. Maurizis,J. C. Madelmont,P. Chollet,P. Armand	2002	8
13	Establishment of IPC 227 cells as human xenografts in rabbits: a model of uveal melanoma P. Bonicel,J. Michelot,F Bacin,Janine Papon,Kémény Jl,Nicole Moins,Daniel Morvan,J. C. Madelmont	2000	13
14	Melanoma-cell toxicity of cystemustine combined with O6-benzyl-N2-acetylguanosine C. Buchdahl,Christine Rolhion,A.‐L. Glasser,Eric Débiton,Emmanuelle Mounetou,J. C. Madelmont,Françoise Laval	1998	6
15	Tissue distribution and metabolism in rat of an ethynesulphonamide with filaricidal activity Nathalie Radembino,M.C. Dessalles,Jean‐Hugues Trouvin,Philippe M. Loiseau,Philippe Gayral,G. Mahuzier,M. Rapp,P. Labarre,D. Godenèche,J. C. Madelmont,J. C. Maurizis,A. Veyre,J. L. Chabard	1997	2
16	Disposition of stiripentol in the pregnant and non-pregnant female rat J. C. Maurizis,M. Rapp,J. C. Madelmont,J. M. Gillardin,F. Lepage,P. Labarre,J. M. Dupuy,A. Veyre	1993	1
17	Disposition and metabolism of acetylcholinesterase reactivators 2PAM-I, TMB4 and R665 in rats submitted to organophosphate poisoning H. Garrigue,J. C. Maurizis,J. C. Madelmont,C. Nicolas,J. M. Meyniel,A. Louvel,P. DEMERSEMAN,H Sentenac-Roumanou,A. Veyre	1991	21
18	Disposition and metabolism of two acetylcholinesterase reactivators, pyrimidoxime and HI6, in rats submitted to organophosphate poisoning H. Garrigue,J. C. Maurizis,C. Nicolas,J. C. Madelmont,D. Godenèche,Thierry Hulot,Xavier Morge,P. DEMERSEMAN,H Sentenac-Roumanou,A. Veyre	1990	29
19	Metabolism of a New Radioprotector; S -Acetyl- N -Glycyl Cysteamine. I. Absorption, Distribution and Excretion Metabolites in Mice Bearing Emt6 Tumours J. C. Maurizis,D. Godenèche,J. C. Madelmont,Marie‐France Moreau,J. Oiry,J.‐L. IMBACH,A. Veyre	1988	4
20	Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatography P. Labarre,D. Godenèche,J. C. Madelmont,K. Triana,G Mathé,A. Veyre	1987	7

About J. C. Madelmont

J. C. Madelmont is a scholar working on Biochemistry, Cancer Research and Pharmaceutical Science, having authored 53 papers that have together received 800 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (8 papers), Cancer therapeutics and mechanisms (8 papers), Cancer, Hypoxia, and Metabolism (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), DNA Repair Mechanisms (4 papers), Cancer Research and Treatments (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Metal complexes synthesis and properties (4 papers). The work is most often cited by research in Biochemistry (83 citations), Biotechnology (88 citations) and Pharmaceutical Science (56 citations). J. C. Madelmont has collaborated with scholars based in France, Canada and Mali. Frequent co-authors include Janine Papon, Daniel Morvan, Aïcha Demidem, J. C. Maurizis, P. Chollet, Eric Cellarier, Nicole Moins, Marie‐Paule Vasson, M.‐C. Farges and Xavier Durando.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact